Resveratrol Promotes Foot Ulcer Size Reduction in Type 2 Diabetes Patients
Figure 1
(a) Cumulative ulcer size of 10 patients in placebo and 14 patients in resveratrol groups over study period. Plots show ulcer size of each patient (solid lines) and mean ulcer size (interrupted bold line) in the study period over 60 days. (b) Ulcer size at baseline and after 30 and 60 days of treatment ( values from Wilcoxon-Mann-Whitney tests).
